They complained about pharmaceutical companies automatically lowering safety standards for clinical trials when they stepped onto the African continent. “Why us?” a prominent African journalist asked Specter. “It seems it’s always us. For how many years does Uganda have to be the test case?”81 “I am very worried about these trials,” said Peter Lurie, the deputy director of Public Citizen’s Health Research Group.
